General
May 4, 2023 - Bedford, MA
WERFEN SIGNS LONG-TERM, EXCLUSIVE WORLDWIDE DISTRIBUTOR AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR HEMOSTASIS TESTING WORKCELL
...
Corporate
March 15, 2023 - Barcelona, Spain
WERFEN COMPLETES ACQUISITION OF IMMUCOR, INC., EXPANDING LEADERSHIP IN SPECIALIZED DIAGNOSTICS
...
Corporate
January 4, 2023 - Bedford, MA
WERFEN RECEIVES 2022 IMV SERVICETRAK AWARDS FOR BEST CUSTOMER SATISFACTION AND BEST SERVICE IN HEMOSTASIS AND BLOOD GAS
...
Acute Care
July 25, 2022 - Bedford, MA
WERFEN ANNOUNCES WORLDWIDE COMMERCIAL RELEASE OF GEMWEB® LIVE REAL-TIME ONSCREEN VIEWER
...
Acute Care
July 18, 2022 - Bedford, MA
WERFEN RECEIVES US FDA 510(K) CLEARANCE FOR ROTEM® SIGMA THROMBOELASTOMETRY SYSTEM
...
Hemostasis
March 28, 2022 - Bedford, MA
Werfen Awarded 2021 IMV ServiceTrak Awards for Best System Performance and Service
...
Acute Care
January 4, 2022 - Bedford, MA
WERFEN RECEIVES US FDA 510(K) CLEARANCE FOR GEM® HEMOCHRON™ 100 WHOLE BLOOD HEMOSTASIS TESTING SYSTEM
...
General
July 12, 2021 - Barcelona, Spain
WERFEN COMPANIES UNITE UNDER ONE NAME AND ONE BRAND
...
Autoimmunity
June 29, 2021 - San Diego
Inova Diagnostics Announces FDA 510(k) Clearance for Aptiva®, a Multi-Analyte System
...
Autoimmunity
May 10, 2021 - San Diego
QUANTA Flash® SARS-CoV-2 IgG Receives Emergency Use Authorization from FDA
...
Autoimmunity
February 23, 2021 - San Diego
NOVA Lite® DAPI dsDNA Crithidia luciliae Kit for NOVA View® Receives FDA Clearance
...
Acute Care
December 29, 2020 - Bedford, MA
INSTRUMENTATION LABORATORY AWARDED MASSACHUSETTS LIFE SCIENCES CENTER TAX INCENTIVE
...
Hemostasis
September 22, 2020 - Bedford, MA
Instrumentation Laboratory Receives US FDA Marketing Authorization For The First Apixaban Diagnostic Test
...
Corporate
August 10, 2020 - Bedford, MA
INSTRUMENTATION LABORATORY AWARDED 2020 IMV SERVICETRAK AWARDS FOR BEST SYSTEM PERFORMANCE, SERVICE AND CUSTOMER SATISFACTION
...
Corporate
May 12, 2020 - Bedford, MA
INSTRUMENTATION LABORATORY WORLDWIDE SALES CONTINUE UPWARD TRAJECTORY IN 2019
...
